| scholarly article | Q13442814 |
| P819 | ADS bibcode | 1991PNAS...88.6931P |
| P356 | DOI | 10.1073/PNAS.88.16.6931 |
| P932 | PMC publication ID | 52207 |
| P698 | PubMed publication ID | 1871109 |
| P5875 | ResearchGate publication ID | 21285094 |
| P2093 | author name string | J Uitto | |
| M G Mattei | |||
| M L Chu | |||
| D T Woodley | |||
| E A Bauer | |||
| K C Wynn | |||
| M G Parente | |||
| L C Chung | |||
| J Ryynänen | |||
| P2860 | cites work | Type VII collagen forms an extended network of anchoring fibrils | Q24680222 |
| Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease | Q26778460 | ||
| Efficient isolation of genes by using antibody probes | Q27860543 | ||
| Cleavage of type VII collagen by interstitial collagenase and type IV collagenase (gelatinase) derived from human skin | Q28250995 | ||
| Bullous pemphigoid antigen (BPAG1): cDNA cloning and mapping of the gene to the short arm of human chromosome 6 | Q28270487 | ||
| New perspectives in cell adhesion: RGD and integrins | Q28280381 | ||
| The tissue form of type VII collagen is an antiparallel dimer | Q28645689 | ||
| A symmetrical, extracellular fibril | Q30494616 | ||
| Epidermolysis bullosa acquisita antigen is the globular carboxyl terminus of type VII procollagen | Q35585890 | ||
| Formation and origin of basal lamina and anchoring fibrils in adult human skin | Q36192225 | ||
| The structure and function of type VII collagen | Q37922168 | ||
| The family of collagen genes | Q37943255 | ||
| Cloning and characterization of five overlapping cDNAs specific for the human proα 1(I) collagen chain | Q40465955 | ||
| Type VII collagen is a major structural component of anchoring fibrils | Q41511070 | ||
| Subepithelial fibrils associated with the basal lamina under simple epithelia in mouse uterus: possible tropocollagen aggregates | Q42443818 | ||
| Ontogeny of Structural Components at the Dermal-Epidermal Junction in Human Embryonic and Fetal Skin: The Appearance of Anchoring Fibrils and Type VII Collagen | Q42518179 | ||
| Primary structural requirements for the enzymatic formation of the N-glycosidic bond in glycoproteins. Studies with natural and synthetic peptides | Q43763164 | ||
| Human cellular fibronectin: comparison of the carboxyl-terminal portion with rat identifies primary structural domains separated by hypervariable regions | Q48378907 | ||
| A Mouse Monoclonal Antibody Against a Newly Discovered Basement Membrane Component, the Epidermolysis Bullosa Acquisita Antigen | Q61041066 | ||
| Suppression of ornithine decarboxylase gene expression by retinoids in cultured human keratinocytes | Q68693967 | ||
| Epidermolysis bullosa acquisita antigen is synthesized by human keratinocytes cultured in serum-free medium | Q68939672 | ||
| Epidermolysis bullosa acquisita antigen is synthesized by both human keratinocytes and human dermal fibroblasts | Q68947963 | ||
| DNA probe localization at 18p113 band by in situ hybridization and identification of a small supernumerary chromosome | Q70072998 | ||
| Large complex globular domains of type VII procollagen contribute to the structure of anchoring fibrils | Q70142439 | ||
| Identification of the Skin Basement-Membrane Autoantigen in Epidermolysis Bullosa Acquisita | Q70334258 | ||
| Collagen biosynthesis by human skin fibroblasts. I. Optimization of the culture conditions for synthesis of type I and type III procollagens | Q71178216 | ||
| DNA sequencing with chain-terminating inhibitors | Q22066207 | ||
| Isolation of complementary DNA for bullous pemphigoid antigen by use of patients' autoantibodies | Q24338971 | ||
| Improved tools for biological sequence comparison | Q24652199 | ||
| P433 | issue | 16 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 6931-5 | |
| P577 | publication date | 1991-08-15 | |
| P1433 | published in | Proceedings of the National Academy of Sciences of the United States of America | Q1146531 |
| P1476 | title | Human type VII collagen: cDNA cloning and chromosomal mapping of the gene | |
| P478 | volume | 88 |
| Q72691286 | A homozygous insertion-deletion in the type VII collagen gene (COL7A1) in Hallopeau-Siemens dystrophic epidermolysis bullosa |
| Q28270168 | A missense mutation in type VII collagen in two affected siblings with recessive dystrophic epidermolysis bullosa |
| Q43978037 | A mutation-independent therapeutic strategy for dominant dystrophic epidermolysis bullosa |
| Q28188253 | A new FACIT of the collagen family: COL21A1 |
| Q30650123 | Aminoglycosides restore full-length type VII collagen by overcoming premature termination codons: therapeutic implications for dystrophic epidermolysis bullosa. |
| Q86754479 | Autoantibodies to Multiple Epitopes on the Non-Collagenous-1 Domain of Type VII Collagen Induce Blisters |
| Q72080159 | Autoantibodies to Type VII Collagen Recognize Epitopes in a Fibronectin-Like Region of the Noncollagenous (NC1) Domain |
| Q52542277 | Autoantibodies to type VII collagen have heterogeneous subclass and light chain compositions and their complement-activating capacities do not correlate with the inflammatory clinical phenotype. |
| Q40719797 | Autoantibodies to type VII collagen mediate Fcgamma-dependent neutrophil activation and induce dermal-epidermal separation in cryosections of human skin |
| Q37295360 | Autoimmunity against type VII collagen in inflammatory bowel disease |
| Q41452411 | Basement-membrane stromal relationships: interactions between collagen fibrils and the lamina densa |
| Q36438308 | Basic fibroblast growth factor: a missing link between collagen VII, increased collagenase, and squamous cell carcinoma in recessive dystrophic epidermolysis bullosa |
| Q47566040 | Bullous diseases. Introduction. |
| Q74561973 | Bullous systemic lupus erythematosus: detection of antibodies against noncollagenous domain of type VII collagen |
| Q35249597 | Characterization of 18 new mutations in COL7A1 in recessive dystrophic epidermolysis bullosa provides evidence for distinct molecular mechanisms underlying defective anchoring fibril formation |
| Q39599980 | Characterization of molecular mechanisms underlying mutations in dystrophic epidermolysis bullosa using site-directed mutagenesis |
| Q47577078 | Characterization of mutations of the type VII collagen gene (COL7A1) in recessive dystrophic epidermolysis bullosa mitis (M-RDEB) from three Korean patients |
| Q37055162 | Clinical presentation, pathogenesis, diagnosis, and treatment of epidermolysis bullosa acquisita |
| Q83202785 | Cloning of genes for basement membrane proteins and discovery of mutations in epidermolysis bullosa |
| Q52526907 | Collagen VII expression in human chronic wounds and scars. |
| Q40853815 | Collagens and their abnormalities in a wide spectrum of diseases |
| Q39550824 | Deletion of the R78 G protein-coupled receptor gene from rat cytomegalovirus results in an attenuated, syncytium-inducing mutant strain. |
| Q36920719 | Detection of Type VII Collagen Autoantibodies Before the Onset of Bullous Systemic Lupus Erythematosus. |
| Q40878358 | Development and characterization of a recombinant truncated type VII collagen "minigene". Implication for gene therapy of dystrophic epidermolysis bullosa |
| Q33610536 | Diagnostic dilemma of "sporadic" cases of dystrophic epidermolysis bullosa: a new dominant or mitis recessive mutation? |
| Q40872692 | Dohi memorial lecture. Clinical implications of basic research on heritable skin diseases |
| Q24312098 | Dominant dystrophic epidermolysis bullosa: identification of a Gly-->Ser substitution in the triple-helical domain of type VII collagen |
| Q35630799 | Dystrophic epidermolysis bullosa |
| Q47757580 | Dystrophic epidermolysis bullosa with one dominant and one recessive mutation of the COL7A1 gene in a child with deafness |
| Q38078021 | Epidermolysis bullosa acquisita |
| Q72324762 | Epidermolysis bullosa acquisita--successful treatment with colchicine |
| Q40399909 | Epidermolysis bullosa: hereditary skin fragility diseases as paradigms in cell biology |
| Q33904940 | Epitope mapping of type VII collagen. Identification of discrete peptide sequences recognized by sera from patients with acquired epidermolysis bullosa |
| Q40305007 | Expression of integrins and basement membrane components by wound keratinocytes |
| Q28305245 | Expression of laminin, type IV procollagen and 230 kDa bullous pemphigoid antigen genes by keratinocytes and fibroblasts in culture: application of the polymerase chain reaction for detection of small amounts of messenger RNA |
| Q35822369 | Genetic linkage of recessive dystrophic epidermolysis bullosa to the type VII collagen gene |
| Q35599586 | Genetic linkage of type VII collagen (COL7A1) to dominant dystrophic epidermolysis bullosa in families with abnormal anchoring fibrils |
| Q33675218 | Genetic linkage to the type VII collagen gene (COL7A1) in 26 families with generalised recessive dystrophic epidermolysis bullosa and anchoring fibril abnormalities |
| Q35196848 | Human type VII collagen: genetic linkage of the gene (COL7A1) on chromosome 3 to dominant dystrophic epidermolysis bullosa |
| Q38608315 | Immune mechanism-targeted treatment of experimental epidermolysis bullosa acquisita. |
| Q73567120 | Immunomapping of EBA sera to multiple epitopes on collagen VII: further evidence that anchoring fibrils originate and terminate in the lamina densa |
| Q67473942 | In situ localization of IgG in epidermolysis bullosa acquisita by immunogold technique |
| Q33712943 | Injection of recombinant human type VII collagen corrects the disease phenotype in a murine model of dystrophic epidermolysis bullosa |
| Q28239509 | Interactions of the amino-terminal noncollagenous (NC1) domain of type VII collagen with extracellular matrix components. A potential role in epidermal-dermal adherence in human skin |
| Q45877035 | Intradermal injection of lentiviral vectors corrects regenerated human dystrophic epidermolysis bullosa skin tissue in vivo |
| Q67466063 | Keratinocytes and Fibroblasts from a Patient with Mutilating Dystrophic Epidermolysis Bullosa Synthesize Drastically Reduced Amounts of Collagen VII: Lack of Effect of Transforming Growth Factor-β |
| Q24676762 | Laminin 5 binds the NC-1 domain of type VII collagen |
| Q34071975 | Laminins and human disease |
| Q33594092 | Linkage of autosomal dominant dystrophic epidermolysis bullosa in three British families to the marker D3S2 close to the COL7A1 locus |
| Q24672000 | Localization of a gene for autosomal dominant Larsen syndrome to chromosome region 3p21.1-14.1 in the proximity of, but distinct from, the COL7A1 locus |
| Q40511466 | Molecular basis for the dystrophic forms of epidermolysis bullosa: mutations in the type VII collagen gene |
| Q24309362 | Molecular basis of dystrophic epidermolysis bullosa: mutations in the type VII collagen gene (COL7A1) |
| Q34412417 | Molecular complexity of the cutaneous basement membrane zone |
| Q35335841 | Molecular genetics of the cutaneous basement membrane zone. Perspectives on epidermolysis bullosa and other blistering skin diseases |
| Q34403741 | Molecular organization of the cutaneous basement membrane zone |
| Q33657782 | Mutation analysis and molecular genetics of epidermolysis bullosa |
| Q68092879 | New nucleotide sequence data on the EMBL File Server |
| Q24562156 | Premature termination codons on both alleles of the type VII collagen gene (COL7A1) in three brothers with recessive dystrophic epidermolysis bullosa |
| Q36437677 | Prenatal diagnosis for recessive dystrophic epidermolysis bullosa in 10 families by mutation and haplotype analysis in the type VII collagen gene (COL7A1) |
| Q34218525 | Prevalence of collagen VII-specific autoantibodies in patients with autoimmune and inflammatory diseases |
| Q35889613 | Recurrent nonsense mutations within the type VII collagen gene in patients with severe recessive dystrophic epidermolysis bullosa |
| Q48133256 | Serological diagnostics in the detection of IgG autoantibodies against human collagen VII in epidermolysis bullosa acquisita: a multicentre analysis. |
| Q40817995 | The carboxyl terminus of type VII collagen mediates antiparallel dimer formation and constitutes a new antigenic epitope for epidermolysis Bullosa acquisita autoantibodies |
| Q71654153 | The epitope for anti-type VII collagen monoclonal antibody (LH7:2) locates at the central region of the N-terminal non-collagenous domain of type VII collagen |
| Q34355367 | The genetics of human skin disease |
| Q36360074 | The modular architecture of vertebrate collagens |
| Q41120437 | The molecular basis for inherited bullous diseases |
| Q38294958 | The recombinant expression of full-length type VII collagen and characterization of molecular mechanisms underlying dystrophic epidermolysis bullosa |
| Q42461921 | The role of laminins in basement membrane function |
| Q41815771 | Topical application of recombinant type VII collagen incorporates into the dermal-epidermal junction and promotes wound closure |
| Q36531284 | Transforming growth factor-beta stimulates collagen VII expression by cutaneous cells in vitro |
| Q34358544 | Type A modules: interacting domains found in several non-fibrillar collagens and in other extracellular matrix proteins |
| Q35596318 | Type VII collagen gene expression by cultured human cells and in fetal skin. Abundant mRNA and protein levels in epidermal keratinocytes |
| Q37640771 | Type VII collagen: the anchoring fibril protein at fault in dystrophic epidermolysis bullosa |
| Q42440155 | Ultrastructural differentiation of epidermolysis bullosa subtypes and porphyria cutanea tarda |
| Q28587373 | WARP is a new member of the von Willebrand factor A-domain superfamily of extracellular matrix proteins |
Search more.